Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -18.61% is 50% above its 5-year average of -37.40%, near the high end of its 5-year range (-62.10%–-12.94%).
As of the fiscal period ended Tuesday, June 30, 2026. 43.90% above its 12-month average of -33.17%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -18.61%.
RETURN ON INVESTED CAPITAL (ROIC)
-18.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-33.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-36.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-37.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+43.90%
CURRENT VS 3Y AVG
+48.65%
CURRENT VS 5Y AVG
+50.24%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+47.81%
vs the sector median at left
Instil Bio, Inc.
Market Cap
$46.69M
Return on Invested Capital (ROIC)
-18.61%
TTM Avg
-33.17%
3Y Avg
-36.24%
5Y Avg
-37.40%
Market Cap
$45.73M
Return on Invested Capital (ROIC)
-192.99%
TTM Avg
-98.03%
3Y Avg
-92.21%
5Y Avg
-72.34%
Market Cap
$47.98M
Return on Invested Capital (ROIC)
-30.75%
TTM Avg
-66.28%
3Y Avg
-31.28%
5Y Avg
-35.56%
Market Cap
$48.53M
Return on Invested Capital (ROIC)
-2441.49%
TTM Avg
-1590.42%
3Y Avg
-842.10%
5Y Avg
-573.16%
Market Cap
$44.72M
Return on Invested Capital (ROIC)
-156.97%
TTM Avg
-119.62%
3Y Avg
-76.34%
5Y Avg
-59.98%
Market Cap
$44.71M
Return on Invested Capital (ROIC)
2.80%
TTM Avg
30.48%
3Y Avg
30.48%
5Y Avg
-223.44%
Market Cap
$48.76M
Return on Invested Capital (ROIC)
-26.51%
TTM Avg
-172.21%
3Y Avg
-183.20%
5Y Avg
-141.01%
Market Cap
$48.77M
Return on Invested Capital (ROIC)
-80.88%
TTM Avg
-50.20%
3Y Avg
-60.46%
5Y Avg
-55.02%
Market Cap
$48.89M
Return on Invested Capital (ROIC)
-35.63%
TTM Avg
-5.31%
3Y Avg
3.75%
5Y Avg
-0.82%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Instil Bio, Inc. (TIL) | $46.69M | -18.61% | -33.17% | -36.24% | -37.40% |
| Celularity Inc. (CELU)vs › | $45.73M | -192.99% | -98.03% | -92.21% | -72.34% |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | -30.75% | -66.28% | -31.28% | -35.56% |
| Apollomics, Inc. (APLM)vs › | $48.53M | -2441.49% | -1590.42% | -842.10% | -573.16% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | -156.97% | -119.62% | -76.34% | -59.98% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 2.80% | 30.48% | 30.48% | -223.44% |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | -26.51% | -172.21% | -183.20% | -141.01% |
| TELA Bio, Inc. (TELA)vs › | $48.77M | -80.88% | -50.20% | -60.46% | -55.02% |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | -35.63% | -5.31% | 3.75% | -0.82% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | -14.57% | -26.81% | -19.60% | -18.89% |
ROIC
-18.6%
ROE
-28.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -18.61% |
| 2026-03-31 | -27.61% |
| 2025-12-31 | -39.55% |
| 2025-09-30 | -39.06% |
| 2025-06-30 | -41.04% |
| 2025-03-31 | -34.66% |
| 2024-12-31 | -26.96% |
| 2024-09-30 | -26.80% |
| 2024-06-30 | -39.92% |
| 2024-03-31 | -40.77% |
| 2023-12-31 | -50.47% |
| 2023-09-30 | -62.10% |
| 2023-06-30 | -49.47% |
| 2023-03-31 | -57.58% |
| 2022-12-31 | -50.40% |
| 2022-09-30 | -45.53% |
| 2022-06-30 | -39.93% |
| 2022-03-31 | -35.17% |
| 2021-12-31 | -27.36% |
| 2021-09-30 | -19.39% |
| 2021-06-30 | -12.94% |
| 2021-03-31 | -7.83% |
| 2020-12-31 | -11.00% |
